After being informed about the study all patients giving written informed consent will be distributed a questionnaire asking questions on bowel function, urinary function, pain, sexual function and lymphedema. All these aspects will be investigated using validated questionnaires.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who have undergone intended curative CRS+HIPEC for peritoneal metastases originated from colorectal cancer (HIPEC cohort) according to national Danish guidelines
Patients who have undergone intended curative total or anterior pelvic exenteration (PE cohort) for advanced or recurrent colorectal cancer according to national Danish guidelines
You may not be if
Patients under 18 years
Patients not speaking Danish or Swedish, respectively, in Denmark and Sweden
Patients unable to give informed consent
Patients undergoing CRS+HIPEC or PE for cancers others than CRC
Terminally ill patients
Clareo Health | Late Organ Specific Adverse Effects hiPec or pElvic eXenteration
